艾滋病毒暴露前预防 处方,同意法律和青少年吸收障碍
Erika G Martin1, Montserrat Avila Acosta1, Dawn A Pepin2
1Department of Public Administration and Policy, Rockefeller College of Public Affairs and Policy, University at Albany, Albany, New York.
Pediatrics
|September 18, 2025
概括
拥有未成年同意法律 (MCLs) 的州没有显示年轻青少年中HIV暴露前预防 (PrEP) 的处方填充量增加. 接入障碍仍然存在,这凸显了需要改进的策略,以确保所有青少年都能获得PrEP.
科学领域:
- 公共卫生 公共卫生
- 青少年健康 青少年健康
- 预防艾滋病毒 预防艾滋病毒
背景情况:
- 艾滋病毒暴露前预防 (PrEP) 是一种安全有效的预防艾滋病毒感染方法,于2018年批准用于青少年.
- 未成年人同意法律 (MCLs) 允许年轻的青少年在没有父母同意的情况下获得PrEP,这可能会改善获得的机会.
研究的目的:
- 评估MCLs允许未成年人同意PrEP的州是否与增加的PrEP处方填充相关.
- 确定青少年在获得PrEP时面临的障碍.
主要方法:
- 法律审查根据MCLs对各州进行了分类.
- 负二项式回归分析了国家药房索赔 (2015-2021年),比较MCL州和非MCL州的未成年人 (13-17岁) 和年轻成年人 (18-19岁) 的PrEP填充.
- 关键信息人采访 (n=25) 提供了定性背景.
主要成果:
- 未成年人的PrEP填充量明显低于年轻人 (IRR=0.21).
- 没有发现MCL和PrEP填充的年龄组之间的显著相互作用,这表明在两种状态类型中,与年龄相关的差异相似.
- 专家指出,保密性,诊所接入,耻辱,提供者犹和有限的教育是关键障碍.
结论:
- 该研究没有发现MCLs减少了未成年人和年轻成年人之间的PrEP处方填充差距的证据.
- 对于青少年获得PrEP的重要障碍仍然存在.
- 需要有针对性的策略来克服这些障碍,并改善青少年之间的PrEP吸收.
相关概念视频
Sexually Transmitted Infections
936
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
936
Retrovirus Life Cycles
49.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K


